Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals-Reference-Cited by-同舟云学术

Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals

Published:2024-01 Issue:1 Volume:22 Page:194-196.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Kushner Tatyana^ORCID,Lange Marcia,Argiriadi Pamela A.,Meislin Rachel,Sigel Keith,Terrault Norah,Rosenbluth Emma,Carroll Carin,Worthington Theresa,O’Hara Shaelyn,Stone Joanne,Friedman Scott,Rosberger Sonam,Feldman Deborah,Sperling Rhoda

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference12 articles.

1. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study

2. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes

3. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease

4. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrahepatic cholestasis of pregnancy: Introduction and overview 2024;Obstetric Medicine;2024-09

2. Metabolism-Disrupting Chemical Mixtures during Pregnancy, Folic Acid Supplementation, and Liver Injury in Mother-Child Pairs;2024-06-14

3. Cardiovascular complications during delivery hospitalizations in patients with nonalcoholic fatty liver disease in pregnancy;European Journal of Gastroenterology & Hepatology;2024-06-06

4. Metabolic dysfunction–associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes;Clinical Liver Disease;2024-01

5. The Impact of the Association Between Nonalcoholic Fatty Liver Disease and Intrahepatic Cholestasis of Pregnancy on Maternal and Fetal Outcomes;Cureus;2023-09-26